Since then, a global systematic review of 63 studies from 2024, commissioned by the World Health Organization, also indicated ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the ...

While not yet as widely used for brain cancer as other treatment forms, research continues to explore its potential against these challenging tumors. CAR T-cell therapy genetically modifies a ...

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis.

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis. Previous research suggests that platelet-derived growth ...